Serial Measurements of Molecular and Architectural Responses to Therapy
The purpose of this study to test samples from a patient's cancer can be used to find combinations of drugs that best combat the kind of cancer the patient has. Another purpose of this study is to test patients' cancer cells to understand why cancer drugs stop working.
In this study, we will take blood and tissue sample from patients and test them to determine your complete DNA sequence, called whole genome sequencing. We will do other kinds of genetic testing, also, to understand as much as we can about the kind of cancer you have.
Metastatic Breast Cancer, Metastatic Pancreatic Cancer, Metastatic Prostate Cancer, Acute Myeloid Leukemia
Confirmed diagnosis of either prostate cancer, breast cancer, pancreatic cancer that has spread to other organs or acute myeloid leukemia.
21 - 99
Healthy Volunteers Needed
Duration of Participation
Participant’s investigational treatment may last for 6 cycles or 6 months of investigational therapy. Participants will be followed for 12 months after their last treatment.
Swapnil Parmar, email@example.com, 503-494-9642
OHSU Knight Cancer Institute